Back to 
CANTOR FITZGERALD, L. P.
CANTOR FITZGERALD, L. P.
IOVA2 quarters
Position history for CANTOR FITZGERALD, L. P.'s holdings in IOVANCE BIOTHERAPEUTICS INC
No. Cantor Fitzgerald exited its IOVA (Iovance Biotherapeutics) position in Q2 2025. Its Q1 2025 13F listed 254,879 shares worth $848,747. Cantor Fitzgerald first reported IOVA in Q1 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$848,747
Total Shares Change
-254,879
Quarter-by-Quarter History
Other major holders of IOVA: ARK Investment Management LLC, FRANKLIN TEMPLETON INC, Avoro Capital Advisors LLC